1. Introduction
===============

Group B1 *Sox* genes, *Sox1*, *Sox2* and *Sox3*, encode HMG-domain transcription factors that show almost identical activity in the activation of target genes in transactivation assays \[[@B1-biology-01-00714],[@B2-biology-01-00714],[@B3-biology-01-00714]\], which is consistent with the model of their derivation from the same ancestral gene as a consequence of genome duplications \[[@B4-biology-01-00714]\]. In embryos, these B1 Sox factors regulate neuro-sensory development \[[@B5-biology-01-00714]\] in a functionally redundant manner when their expression overlaps in tissue. In most vertebrate species, the expression of *Sox2* and *Sox3*, which are activated in the early stages of embryogenesis, occurs prominently in the epiblast and neuro-sensory primordia \[[@B5-biology-01-00714],[@B6-biology-01-00714],[@B7-biology-01-00714],[@B8-biology-01-00714],[@B9-biology-01-00714],[@B10-biology-01-00714],[@B11-biology-01-00714],[@B12-biology-01-00714],[@B13-biology-01-00714]\]. In contrast, *Sox1* is activated at much later stages than *Sox2* and *Sox3* \[[@B5-biology-01-00714],[@B6-biology-01-00714],[@B7-biology-01-00714],[@B14-biology-01-00714],[@B15-biology-01-00714]\].

The most compelling evidence for the redundant functions and resulting functional compensation among B1 *Sox* genes has been provided by a study using zebrafish, where the developmental defects became evident only when activities of all B1 *Sox* genes expressed at early stages were downregulated \[[@B16-biology-01-00714]\]. In mouse embryos, the functional compensation between *Sox2* and *Sox3* has been indicated by the occurrence of embryonic lethality from *Sox2*+/-; *Sox3*-/- compound mutations, despite the viability of the *Sox2*+/- and *Sox3*-/- animals \[[@B17-biology-01-00714]\]. In addition, *Sox3* activity compensates for the loss of *Sox2* expression in the epiblast of post-gastrulation embryos \[[@B18-biology-01-00714]\].

The consequence of sharing of functions among the B1 *Sox* genes is that the targeted disruption of *Sox1*, *Sox2* or *Sox3* resulted in defective phenotypes only in the specific organs uniquely expressing these transcription factors. *Sox1*-mutant mice show abnormal lenses \[[@B19-biology-01-00714]\] and ventral striatum \[[@B20-biology-01-00714]\]. *Sox2*-mutant embryos die around the implantation stage, because *Sox2* is the only B1 *Sox* expressed at that stage \[[@B21-biology-01-00714]\]. *Sox3*-deficient embryos specifically develop abnormalities in the pituitary gland \[[@B22-biology-01-00714]\], gonad \[[@B23-biology-01-00714]\], and pharyngeal arch morphogenesis \[[@B17-biology-01-00714]\].

Functional dominance between *Sox2* and *Sox3* depends on the animal species. In amniotes, e.g., human, mouse and chicken, *Sox2* expression covers the entire neural primordia, and it is considered the lead transcription factor gene in primordial neural cells \[[@B24-biology-01-00714],[@B25-biology-01-00714]\]. However, in lower vertebrates, *Sox3* expression is more prevalent in the neural primordia than *Sox2* expression \[[@B8-biology-01-00714],[@B9-biology-01-00714],[@B12-biology-01-00714],[@B26-biology-01-00714]\], suggesting an evolutionary shift in the major regulatory processes in early neurogenesis from *Sox3*-centered regulation to *Sox2*-centered regulation in order to fulfill the equivalent B1 *Sox* functions \[[@B4-biology-01-00714]\]. Although the expression domains of *Sox2* and *Sox3* overlap extensively, their expression patterns are not identical, indicating differences in the regulation of these two B1 *Sox* genes. However, the regulation of *Sox2* and *Sox3* must be coordinated in the developmental processes that depend on the overall B1 Sox activity level.

Therefore, the regulation of the *Sox2* and *Sox3* genes is essential for the proper development of neural and sensory tissues. We previously identified more than 20 enhancers that are distributed in a 200-kb genomic region encompassing the *Sox2* gene \[[@B27-biology-01-00714],[@B28-biology-01-00714]\]. Each of these *Sox2* enhancers was regulated in a unique manner, reflecting particular mechanisms that operate in specific tissues and/or at specific stages of neuro-sensory development \[[@B3-biology-01-00714],[@B18-biology-01-00714],[@B29-biology-01-00714],[@B30-biology-01-00714]\]. Many of these enhancers are conserved in DNA sequences across vertebrate species \[[@B4-biology-01-00714],[@B18-biology-01-00714],[@B27-biology-01-00714],[@B28-biology-01-00714]\], indicating strong conservation of the mechanisms of tissue regulation involving *Sox2* function. The N2 enhancer, which is responsible for *Sox2* activation in the epiblast and early anterior neural plate, is regulated by Zic, Pou and Otx factors \[[@B18-biology-01-00714],[@B31-biology-01-00714]\]. In contrast, the *Sox2* N1 enhancer of *Sox2* is activated in the caudal lateral epiblast adjacent to the primitive streak. Axial stem cells, which are bipotential precursors for the neural plate and the paraxial mesoderm, reside in the caudal lateral epiblast \[[@B32-biology-01-00714]\], and produce neural and mesodermal cells, depending on whether *Sox2* or *Tbx6* is activated \[[@B33-biology-01-00714]\]. In addition, it has been shown that both axial stem cell maintenance and N1 enhancer activation depend on Wnt and Fgf signals \[[@B29-biology-01-00714],[@B32-biology-01-00714],[@B33-biology-01-00714],[@B34-biology-01-00714]\].

In this study, we report a systematic survey and characterization of the enhancers that regulate the *Sox3* gene in neuro-sensory development. Many enhancers were found in the 231-kb span of the *Sox3*-encompassing chicken genomic region, as was the case for *Sox2* enhancers. In some cases, the enhancers were similarly regulated between the *Sox3* and *Sox2* genes. However, the varieties of enhancer specificities in spatial and temporal terms were substantially different between these genes. The *Sox3* NP1 enhancer that was activated in the caudal lateral epiblast was analyzed in detail because of its similarity to the *Sox2* N1 enhancer. The *Sox3* NP1 enhancer was found to be regulated by Wnt and Fgf signals, similar to the *Sox2* N1 enhancer, which is consistent with the essential involvement of Wnt and Fgf signaling in axial stem cell regulation \[[@B32-biology-01-00714]\].

A previous study using transgenic mouse embryos identified three putative enhancers within the genomic span, 3 kb upstream and downstream of the *Sox3* gene, which directs gene expression in distinct domains of the neural primordia \[[@B35-biology-01-00714]\]. In addition, an analogous *Sox3*-proximal DNA sequence of *Xenopus laevis* can reproduce a part of the *Sox3* expression patterns in transgenic frogs \[[@B12-biology-01-00714]\]. Our present study screened a wider genomic region and found more varieties of enhancers that regulate the *Sox3* gene in neuro-sensory development.

2. Results
==========

2.1. Distribution of the Conserved Sequence Blocks (CSBs) in the Region Surrounding the Sox3 Gene Locus in Various Vertebrate Species
-------------------------------------------------------------------------------------------------------------------------------------

The *Sox3* gene is located on the X-chromosome in mammals, but it is autosomal in other vertebrate species. It is located on chromosome 4 in chicken, on scaffold GL172698.1 (without chromosomal assignment) in *Xenopus tropicalis*, on chromosome 14 in zebrafish, and on chromosome 10 in medaka ([Figure S1](#biology-01-00714-f007){ref-type="fig"}). As the majority of enhancer sequences are included in the sequence blocks that are strongly conserved across the species (\>60% DNA sequence identity over a length of 100 bp) \[[@B27-biology-01-00714]\], we compared the distribution of CSBs. As shown in [Figure 1](#biology-01-00714-f001){ref-type="fig"} and [Table S1](#biology-01-00714-t001){ref-type="table"}, many sequence blocks conserved between chicken and mammals and/or between chicken and *Xenopus* were identified both upstream and downstream of the *Sox3* gene. In fish genomes, a fraction of the blocks were identified, but the degrees of sequence conservation were generally low (data not shown). CSBs present in the chicken genome were numbered from 1 to 47. These blocks were located in the region that was between 134 kb upstream and 97 kb downstream relative to the *Sox3* open reading frame (ORF) start site (231 kb total), whereas in mammalian genomes the same conserved sequences were distributed in wider regions (940 kb in the mouse and 1.4 Mb in the human). Upstream CSBs from block 1 to 11 tend to be shorter (average 163 bp) compared to the entire CSBs (average 309 bp, excluding \~1 kb block 23 that included *Sox3* ORF). However, downstream of block 47, no CSBs were found between chicken and other animal species. From these observations, the 231-kb span of the chicken genome encompassing the *Sox3* gene was subjected to an enhancer survey.

![Comparison of the genome sequence organization of the *Sox3*-encompassing regions of human, mouse, chicken and Xenopus. The arrangement of the conserved sequence blocks (CSBs) that were numbered 1 to 47 in the region, between 134 kb upstream and 97 kb downstream, of the chicken *Sox3* gene. A CSB is defined as a sequence that shows \>60% base identity compared with the chicken genome of more than a 100 bp sequence. The corresponding CSBs in different genomes bear the same numbers as in the chicken. The spacing between CSBs are similar for chicken and Xenopus genomes, but are widened in mammalian genomes. Human CSB1 positioned at -970 kb is not included in this Figure. Downstream, the correspondence between the mammalian and chicken sequences is lost beyond CSB47. The genomic coordinates of the CSBs in each genome are given in [Table S1](#biology-01-00714-t001){ref-type="table"}.](biology-01-00714-g001){#biology-01-00714-f001}

2.2. Screening for Enhancer Sequences and Their Characterization
----------------------------------------------------------------

We utilized the tkEGFP vector which by itself does not express EGFP upon electroporation in chicken embryos but expresses EGFP in a tissue-specific manner when an enhancer-bearing genomic fragment is inserted \[[@B27-biology-01-00714],[@B36-biology-01-00714]\]. We initially analyzed the *Sox3*-proximal 50 kb region using bacteriophage clones derived from a chicken genome library. The overlapping DNA fragments C1 to C13 were prepared ([Figure 2](#biology-01-00714-f002){ref-type="fig"}), inserted into the tkEGFP vector, and assessed for enhancer activities. Two regions of the genomic sequence exhibited enhancer activities: C4/5 in the st. 11 lens, and C12/13 in st. 11 diencephalon and spinal cord ([Figure 3](#biology-01-00714-f003){ref-type="fig"} and [Figure 4](#biology-01-00714-f004){ref-type="fig"}, [Table S2](#biology-01-00714-t002){ref-type="table"}). The C12 sequence and the C13 sequence included in C12 exhibited identical enhancer activity. The C4/5 sequence included three CSBs (17, 18 and 19). The cloning of individual CSBs indicated that the CSB19 sequence was responsible for the lens enhancer activity of C4/5. The CSB26 sequence included in the C12 sequence exhibited enhancer activity in the diencephalon and spinal cord, which was identical to the activity of the C12 sequence.

![DNA sequences derived from the *Sox3*-encompassing genome region of the chicken and their analysis for enhancer activities. Distribution of CSBs 1-47 (black bars) upstream and downstream of the *Sox3* gene. CSB23 includes the *Sox3* open reading frame (ORF). The sequences of the central region, C1-C13, were derived from bacteriophage clones. The \~5 kb sequences that were upstream (U1 to U28) and downstream (D1 to D 17) with 1-kb terminal overlaps were derived from BAC clones. The DNA sequences indicated by red horizontal bars exhibited enhancer activity. CSBs 19, 26 and 27 that showed the same activity as the original DNA sequences are marked by red vertical bars. The nucleotide positions of these sequences and the statistics of the enhancer analysis are presented in [Table S2](#biology-01-00714-t002){ref-type="table"}.](biology-01-00714-g002){#biology-01-00714-f002}

![Enhancer activities in placode derivatives of the *Sox3*-flanking sequences or CSBs in electroporated chicken embryos at st. 11-12, as indicated by the EGFP expression, in comparison with *Sox3 in situ* hybridization (left). Top: Bright-field images with indication of developmental stages. V, ventral view; D, dorsal view. Bottom: EGFP fluorescence images of the same field. The bars indicate 200 μm. Di, diencephalon; Ep, epibranchial placode; LP, lens placode; Mes, mesencephalon; OP, otic placode; Rho, rhombencephalon; Tel, telencephalon.](biology-01-00714-g003){#biology-01-00714-f003}

These enhancers accounted for only subdomains of *Sox3* expression in embryos. Therefore, we extended the region of the enhancer survey to a 231-kb genomic span. We identified two BAC clones that covered the upstream and downstream regions of the central 50-kb region. We prepared a series of \~5 kb DNA sequences that spanned the upstream and downstream regions with 1 kb terminal overlaps, resulting in 28 upstream sequences (U1--U28) and 17 downstream sequences (D1--D17) that were external to the central 50-kb sequence ([Figure 2](#biology-01-00714-f002){ref-type="fig"}), and examined their enhancer activities. The number of electroporated specimens for each DNA sequence is indicated in [Table S2](#biology-01-00714-t002){ref-type="table"}, where the same specificity of an enhancer was reproducibly demonstrated.

![Sequential activation of *Sox3* enhancers that show distinct tissue specificities in the neural primordia. The D1 activity was represented by the NP1 enhancer sequence (see also [Figure 5](#biology-01-00714-f005){ref-type="fig"}C). The top row: *Sox3 in situ* hybridization patterns in chicken embryos at respective developmental stages. Other rows, EGFP expression reflecting the specificity of the enhancers in comparison with the bright-field image of the same embryo. The data of an enhancer at different developmental stages was taken from the same embryo. V, ventral view; D, dorsal view. The white triangles indicate the positions of Hensen's node. All photographs are shown on the same scale. The bar indicates 500 μm. Di, diencephalon; Mes, mesencephalon; Rho, rhombencephalon; SC, spinal cord; Tel, telencephalon.](biology-01-00714-g004){#biology-01-00714-f004}

In the upstream region, we identified only one sequence, U3, which showed enhancer activity in the epibranchial placode region at st. 11. However, in the downstream 97 kb region, ten sequences showed enhancer activities of various tissue specificities ([Figure 3](#biology-01-00714-f003){ref-type="fig"} and [Figure 4](#biology-01-00714-f004){ref-type="fig"}, [Table S2](#biology-01-00714-t002){ref-type="table"}). The U3, D1, D3, D5 and D8 sequences showed enhancer activities in placode derivatives ([Figure 3](#biology-01-00714-f003){ref-type="fig"}). The D3 sequence showed an otic placode-specific enhancer activity, while the D8 sequence displayed an epibranchial placode-specific activity that was similar to the aforementioned U3 enhancer. Other placodal enhancers also showed enhancer activity in the CNS as well.The D1, D4, D5, D6, D11, D12, D13 and D15 sequences showed enhancer activities in various portions of the developing CNS ([Figure 4](#biology-01-00714-f004){ref-type="fig"}). The enhancer activity of the D1 sequence was of particular interest because of its strong activity in the caudal lateral epiblast, which is similar to the *Sox2* N1 enhancer \[[@B27-biology-01-00714],[@B29-biology-01-00714]\]. The D1 enhancer had additional activity in the posterior neural plate that forms the rhombencephalon and spinal cord. The D1 sequence included CSB27, and the isolated CSB27 sequence alone displayed the same activity (see [Figure 5](#biology-01-00714-f005){ref-type="fig"}C, below). This CSB enhancer was renamed NP1 and analyzed further. The sequence D5 enhancer showed activity in the CNS anterior to the rhombencephalon and in the lens placode, indicating a resemblance to the N3 enhancer of *Sox2*.

2.3. The Time Course of the Activation of Neural Enhancers
----------------------------------------------------------

The tissue territories of activation of the *Sox3* neural enhancers are compared in [Figure 4](#biology-01-00714-f004){ref-type="fig"} following the time course. Shortly after the electroporation of the tkEGFP reporter vector, the NP1 (CSB27) enhancer was activated at st.5 in the region abutting the anterior primitive streak, which is similar to the *Sox2* N1 enhancer \[[@B27-biology-01-00714],[@B29-biology-01-00714]\]. Synchronous with primitive streak regression and the posterior migration of Hensen's node, the peak position of the NP1 enhancer activity moved posteriorly. A moderate level of enhancer activity remained in the region where the enhancer was once activated, namely, in the rhombencephalon and spinal cord. Following the activation of NP1, the D13 and D15 enhancers were activated at st. 8, in the prospective diencephalon, rhombencephalon and anterior spinal cord (D13/15), and in the prospective telencephalon (D15). Later at st. 9, enhancers D4, D5 and D11 were activated in the prospective telencephalon (D4), the prospective di/mesencephalon (D5) and the spinal cord (D11). At st. 11, the CSB26 enhancer was activated in the prospective diencephalon and the medial axial levels of the spinal cord, and the D12 enhancer was activated in the ventral diencephalon. Next, at st. 15, the D6 enhancer was activated in the mes/rhombencephalon and spinal cord. These enhancers produced various overlapping patterns of their activities in the CNS primordium.

2.4. Functional Dissection of the NP1 Enhancer Region
-----------------------------------------------------

In order to examine the NP1 enhancer regulation that was analogous to the *Sox2* N1 enhancer activation in axial stem cells, the DNA sequence of the NP1 enhancer was investigated in detail. A comparison of the CSB27 sequence (369 bp in the chicken) in the four vertebrate species indicated the existence of two conspicuous blocks of high sequence conservation, which were positions 52--177 (Block A) and 185--269 (Block B) ([Figure 5](#biology-01-00714-f005){ref-type="fig"}A).

Starting from a 1681-bp sequence, which included the 369-bp CSB27 sequence, the specific region that accounted for the enhancer sequence was narrowed down in the following steps ([Figure 5](#biology-01-00714-f005){ref-type="fig"}B). The CSB27 sequence showed activity that was identical to the 1681-bp sequence, whereas the immediate upstream 941-bp sequence showed no activity ([Figure 5](#biology-01-00714-f005){ref-type="fig"}B(a)). The deletion analysis shown in [Figure 5](#biology-01-00714-f005){ref-type="fig"}B(b) indicated that the 52 to 269-bp region of the CSB27 sequence was sufficient for full enhancer activity, whereas the sequences bearing only one of the two high-conservation blocks (1--180 bp or 181--369 bp) did not show enhancer activity ([Figure 5](#biology-01-00714-f005){ref-type="fig"}C). The 5' step-wise deletions indicated that the 1 to 81-bp region was dispensable, but further deletion to the 92-bp position inactivated the enhancer. The 10-bp 3' deletion from the 82 to 269-bp sequence inactivated the enhancer. Taken together, these results indicated that the 82 to 269-bp sequence was required for NP1 enhancer activity.

![The sequence requirements for NP1 enhancer activity. **A.** Alignment of the CSB27 sequence of human, mouse, chicken and Xenopus. Two strongly conserved blocks, A and B, are highlighted in blue and pink, respectively. Other conserved bases are shaded in gray. The nucleotide positions in the chicken sequence are given at the top. **B.** Deletion analysis of the NP1 enhancer. The thick dark red lines indicate the DNA sequences showing full NP1 enhancer activity, while the thin gray lines indicate the sequences without enhancer activity. **(a)** A 1,681-bp DNA sequence (NP1\[1681 bp\]) that included the CSB27 sequence showed enhancer activity that was identical to the CSB27 (NP1\[369 bp\]) sequence. **(b)** The 5' and 3' halves of the CSB27 sequence, 1-180 bp and 181-369 bp, which included only one of the strongly conserved blocks, A and B, respectively, did not show NP1 enhancer activity. NP1\[218 bp\], consisting of the strongly conserved blocks A and B, displayed full NP1 activity. While a 30-bp deletion from the 5' end (NP1\[188 bp\]) did not affect the enhancer activity, a 40-bp deletion (92--269 bp) inactivated the enhancer. The sequence of 82-259 bp with a 3' 10-bp deletion from NP1\[188 bp\] lost enhancer activity. Thus, NP1\[188 bp\] was determined as the minimal DNA sequence that elicited NP1 enhancer activity that was definable from external deletions. **C.** Representative examples used to assess NP1 enhancer activity using chicken embryo electroporation. Both bright field and EGFP fluorescence images are shown for each sequence tested. D1 \[5.0 kb\], NP1\[369 bp\] and NP1\[218 bp\] sequences showed strong activity (++), while the 1-180 bp (including Block A) and 181-369 bp (including Block B) sequences were inactive (-). The bar indicates 500 μm.](biology-01-00714-g005){#biology-01-00714-f005}

2.5. Regulation of the NP1 Enhancer by Wnt and Fgf Signals
----------------------------------------------------------

The tissue domain that first activated the *Sox3* NP1 enhancer, namely the caudal lateral epiblast abutting the primitive streak, overlapped with that of the *Sox2* N1 enhancer as indicated in [Figure 6](#biology-01-00714-f006){ref-type="fig"}A(a). The N1 enhancer is activated by the combined action of Wnt and Fgf signals \[[@B29-biology-01-00714],[@B33-biology-01-00714]\], which is consistent with the requirement of both signals in the maintenance of the axial stem cells that activate the N1 enhancer \[[@B32-biology-01-00714],[@B34-biology-01-00714]\]. Thus, whether the NP1 enhancer is also regulated by Wnt and Fgf signals was investigated. The 52-269 sequence of CSB27 contained several potential Lef1 binding sequences and putative Fgf-responsive elements ([Figure 6](#biology-01-00714-f006){ref-type="fig"}A(b)).

When the expression vector for Dkk1, which is an antagonist of canonical Wnt signaling, was co-electroporated with NP1-tkEGFP, the NP1 enhancer was inactivated ([Figure 6](#biology-01-00714-f006){ref-type="fig"}B(b)). In contrast, when the expression vector for stabilized β-catenin, which constitutively activates the canonical Wnt signal pathway, was co-electroporated, the NP1 enhancer was activated in the entire embryo ([Figure 6](#biology-01-00714-f006){ref-type="fig"}B(c)). These results demonstrated the canonical Wnt signal-dependent activation of the NP1 enhancer. Analogously, co-electroporation of a vector to express a soluble form of the Fgf receptor 1 \[FGFR1c(ECD)-Fc(IgG2a)\] that titrates Fgf molecules, or addition to the culture medium of SU5402, a specific inhibitor of Fgf receptor tyrosine kinase, inactivated the enhancer ([Figure 6](#biology-01-00714-f006){ref-type="fig"}B(d)-(f)), indicating that NP1 enhancer activation also depended on Fgf signaling. These findings indicated that the *Sox3* NP1 enhancer was regulated by Wnt and Fgf signals in a manner similar to that of the *Sox2* N1 enhancer, which suggests that both *Sox2* and *Sox3* genes are regulated in an analogous manner in neural/mesodermal-bipotential axial stem cells. This would allow the regulation of these B1 Sox genes to be coordinated with the maintenance and differentiation of axial stem cells, which are also regulated by Wnt and Fgf signaling.

![Regulation of the *Sox3* NP1 enhancer. **A.** Comparison of the *Sox3* NP1 enhancer and *Sox2* N1 enhancer. **(a)** Activities of the NP1 enhancer (NP1-tkEGFP) and N1 enhancer (N1-tkmRFP1) in the same electroporated chicken embryo at st. 9. The NP1 activity was recorded using a shorter exposure compared to other panels, in order to show the distribution of strong enhancer activity posterior to Hensen's node. The node position is indicated by an arrowhead. **(b)** Comparison of the DNA sequences of *Sox3* NP1\[218 bp\] and the 298-bp *Sox2* N1 sequence \[[@B27-biology-01-00714],[@B29-biology-01-00714]\]. The Lef-1 binding motifs are highlighted in pink. The Fgf-responsive element TGTGAC of N1 \[[@B29-biology-01-00714]\], as well as the related sequences in N1 and NP1 which are candidate elements for an Fgf response, are highlighted in blue. **B.** The dependence of NP1 enhancer activity on Wnt and Fgf signaling. Embryos were electroporated with the NP1\[218 bp\]-tkEGFP, pCMV/SV2-mRFP1 (electroporation control), and expression vectors for effectors modulating Wnt/Fgf signaling or treated with SU5402. After 8 hours when the embryos reached \~st. 8, the effects of the effectors on NP1 enhancer activities were assessed. The number of cases showing the same response as shown in the representative panel among the treated embryos is indicated in the NP1-EGFP panels. **(a)** A control embryo with no effectors. **(b)** Dkk1 expression that blocked canonical Wnt signaling inactivated the NP1 enhancer. **(c)** Expression of stabilized β-catenin that constitutively activated canonical Wnt signaling resulted in the strong activation of the NP1 enhancer in the entire embryonic tissue. **(d)** Expression of a soluble form of Fgf receptor that titrates out Fgf ligands inactivated the NP1 enhancer. **(e)** and **(f)** Addition of SU5402 to the culture also inactivated the NP1 enhancer. SU5402 was added at 25 μM **(e)**or 125 μM **(f)** in 50 μl yolk solution that overlaid an embryo \[[@B36-biology-01-00714]\], but not in the supporting agar medium. The bars indicate 500 μm.](biology-01-00714-g006){#biology-01-00714-f006}

3. Discussion
=============

3.1. Regulation of the Sox3 Gene
--------------------------------

The basal promoter of the human *Sox3* gene has been characterized as having binding sites for several tissue-nonspecific transcription factors \[[@B37-biology-01-00714],[@B38-biology-01-00714],[@B39-biology-01-00714]\], suggesting a limited contribution of the promoter in the tissue-specific regulation of the *Sox3* gene. A survey of the mouse genomic sequences within 3 kb of the *Sox3* gene with transgenic mouse embryos identified three regulatory regions that dictate transgene expression: the FB sequence of approximately 200 bp long that was located at approximately -1.2 kb in the coordinates given in [Figure 1](#biology-01-00714-f001){ref-type="fig"} for expression in the forebrain/midbrain /hindbrain; the V2 sequence that was located between -1.1 and 0.3 kb for expression in the V2 interneuron domain of the spinal cord; and the PNT-R sequence located between 2.8 and 4.1 kb, relative to the *Sox3* translational start site for expression in the posterior neural tube, rhombencephalon and otic vesicle \[[@B35-biology-01-00714]\]. Both the FB and V2 sequences were included in the C7 sequence, and PNT-R was included in the C8 sequence ([Figure 1](#biology-01-00714-f001){ref-type="fig"}). Generation of the partial expression pattern of *Sox3* using a *X. laevis Sox3*-proximal sequence has also been reported \[[@B12-biology-01-00714]\].

In our present study, a region of a total of 231 kb in the chicken genome encompassing the *Sox3* locus was systematically surveyed for enhancers with the region-scanning \~5-kb DNA sequences with terminal overlaps, and 13 new enhancers that direct gene expression in specific regions of the neural and/or sensory primordia were identified. A combination of these with the mouse-determined enhancer-like elements, account for various features of *Sox3* regulation in early neuro-sensory development. However, it should be noted that our survey using chicken embryo electroporation did not detect the aforementioned *Sox3*-proximal elements that were determined using transgenic mouse embryos. One possible cause of this discrepancy was differences in the assay method. However, it probably reflected that a negatively acting element that was located around -5 kb of the *Sox3* gene masked the enhancer activities. In transgenic mouse experiments \[[@B35-biology-01-00714]\], it has been reported that inclusion of this region inhibited forebrain activity of the FB element. Presence of an analogous enhancer-inhibitory element has also been reported for the *X. laevis Sox3* upstream sequence \[[@B12-biology-01-00714]\]. The chicken DNA sequences (C7 and C8) covering the *Sox3*-proximal region were assessed as negative and included this -5 kb element, which could have masked the enhancer activities ([Figure 2](#biology-01-00714-f002){ref-type="fig"}).

The *Sox3* expression pattern in the chicken embryos and the activities of the newly identified enhancers are compared in [Figure 3](#biology-01-00714-f003){ref-type="fig"} and [Figure 4](#biology-01-00714-f004){ref-type="fig"}. *Sox3* expression at st. 5 covered both the anterior and posterior neural plates, whereas the NP1 enhancer was active in the posterior neural plate and especially in the posterior axial stem cell region. It is likely that the FB element that was determined with the mouse system \[[@B35-biology-01-00714]\] regulates *Sox3* expression in the anterior neural plate. After st. 8, various enhancers that have activities in the subdomains of the forebrain-midbrain region, *i.e.*, D13, D15, D4, D5, D11, CSB26, D12 and D6, were activated in sequence. This resulted in various overlapping patterns of enhancer activities. In addition, at the rhombencephalon level, plural sequences showed enhancer activity, namely NP1, D13, D15, D6 ([Figure 4](#biology-01-00714-f004){ref-type="fig"}) and PNT-R \[[@B35-biology-01-00714]\]. In the spinal cord, many enhancers showed non-uniform activity along the antero-posterior axis, with exception of the D15 enhancer. The D13 and D6 enhancers showed strong activity in the anterior half of the spinal cord at st. 11, whereas the D11 and CSB26 enhancers showed activity in the medial portion of the spinal cord ([Figure 4](#biology-01-00714-f004){ref-type="fig"}). In the posterior region of the spinal cord, the NP1 and PNT-R enhancers exhibited activities. These observations suggested modular regulation of *Sox3* expression along the antero-posterior axis of the spinal cord that depended on the differential activities of the enhancers.

In sensory tissue development, the D5 enhancer was activated in the lens placode area at st. 11, and the CSB19 enhancer was activated at st. 12 and continued to be active until the later stages of lens development ([Figure 3](#biology-01-00714-f003){ref-type="fig"}). Three enhancers exhibiting activity in the otic placode/vesicle have been identified: the otic placode-specific D3 enhancer, NP1 and PNT-R \[[@B35-biology-01-00714]\]. NP1 and PNT-R showed activity in the posterior neural plate, and the activation of these enhancers in both the otic placode/vesicle and the posterior spinal cord suggested a common signaling input in the development of the two different tissues. The U3 and D8 enhancers showed activities in the epibranchial placode regions.

3.2. Comparison of the Regulation of Sox3 and Sox2
--------------------------------------------------

We have previously shown that during the early stages of neural plate development, *Sox2* regulation is divided into non-overlapping anterior and posterior territories that are regulated by the N2 and N1 enhancers, respectively \[[@B5-biology-01-00714],[@B27-biology-01-00714],[@B32-biology-01-00714]\]. This reflects the fact that the anterior and posterior neural plates develop from the epiblast through distinct cellular mechanisms \[[@B18-biology-01-00714],[@B32-biology-01-00714],[@B33-biology-01-00714]\]. Participation of the two enhancers FB and NP1 in *Sox3* regulation in the anterior and posterior neural plate development, respectively, indicated that *Sox2* and *Sox3* are regulated on the basis of the same antero-posterior spatial division of the neural plate.

In a detailed analysis, an important similarity was found in the regulation of the *Sox3* NP1 and *Sox2* N1 enhancers. Both of these enhancers were activated in the epiblastic tissue abutting the anterior primitive streak in which the axial stem cells reside. Both were activated by the combined action of Wnt and Fgf signals, as inhibition of either of these signals attenuated their enhancer activities ([Figure 6](#biology-01-00714-f006){ref-type="fig"}B) \[[@B29-biology-01-00714],[@B33-biology-01-00714]\]. Multiple Lef1-binding sites are found in the NP1 sequence ([Figure 6](#biology-01-00714-f006){ref-type="fig"}A(b)), and a pair of functional Lef1-binding sites have been determined in the N1 sequence \[[@B29-biology-01-00714],[@B33-biology-01-00714]\]. Putative Fgf-responsive elements were also indicated in both sequences ([Figure 6](#biology-01-00714-f006){ref-type="fig"}A(b)). These shared features of NP1 and N1 allow for the coordinated regulation of *Sox3* and *Sox2* when the axial stem cells give rise to the neural plate and paraxial mesoderm. However, their regulation was not identical. The arrangements of the Lef1 sites and putative Fgf responsive elements were very different between NP1 and N1. In contrast to the case of the N1 enhancer, which was strongly downregulated when the neural plate was formed, the NP1 enhancer maintained its activity in the spinal cord and was also activated in the otic vesicle.

Another analogous case had similar enhancer specificities of the *Sox3* D5 enhancer and *Sox2* N3 enhancer. These enhancers were activated in the forebrain, including the optic vesicle, and in the lens placode in st. 11 chicken embryos. It has been shown that the *Sox2* N3 enhancer is activated by the cooperative action of Sox2 and Pax6 in the diencephalon, optic vesicle and lens placode \[[@B3-biology-01-00714]\]. Considering the similarities in the tissue specificity of the enhancer activity, it is possible that an analogous regulation is involved in the activation of the D5 enhancer. However, their regulation was not identical, while the D5 enhancer was active in the telencephalon at st. 11, the N3 enhancer lacked activity therein. Thus, the case of the D5 enhancer represented an additional example of the analogy between the *Sox3* and *Sox2* regulatory mechanisms, yet with an appreciable difference.

Regulation of the *Sox3* gene in the neural plate progressively became more complex ([Figure 4](#biology-01-00714-f004){ref-type="fig"}). Following the creation of the antero-posterior subdivisions by the FB and NP1 enhancers in the enhancer territories of the forming neural plate, more *Sox3* enhancers with various regional specificities were activated in sequence. The same scenario holds true for *Sox2*-regulating enhancers \[[@B27-biology-01-00714],[@B28-biology-01-00714]\]. However, the activities of individual enhancers differed between *Sox3* and *Sox2* with respect to their aforementioned specificities.

The genomic arrangements of the enhancers also differed between the *Sox3* and *Sox2* genes. For instance, the D5 enhancer that was activated in the ocular primordia was located \~50 kb downstream of the *Sox3* gene, while the N3 enhancer was positioned \~15 kb upstream of the *Sox2* gene. Whereas the major *Sox3* enhancers were distributed in the region between -20 kb and 80 kb relative to the *Sox3* gene \[[@B35-biology-01-00714]\] ([Figure 2](#biology-01-00714-f002){ref-type="fig"}), the *Sox2* enhancers were more widely distributed on both sides of the gene over the range of 200 kb \[[@B28-biology-01-00714]\]. Thus, with respect to their individual activities and genome organizations, the enhancers substantially differed between the *Sox3* and *Sox2* genes.

3.3. Phylogenetic Conservation of Sox3 Regulation
-------------------------------------------------

The wide expression of *Sox3* in the neuro-sensory primordia is common to most vertebrate species, whereas the wide expression of *Sox2* is limited to amniote animals \[[@B4-biology-01-00714]\]. Reflecting this fact, the individual CSBs (potential enhancers) of the *Sox3* locus were strongly conserved among the genomes of *Xenopus*, chicken and mammals ([Figure 1](#biology-01-00714-f001){ref-type="fig"}), which is in contrast to the high degree of conservation of *Sox2*-associated CSBs that are confined to amniotes \[[@B4-biology-01-00714]\].

Along with these general features, species-dependent episodic changes in the enhancers were also observed. The sequence of lens-specific CSB19 enhancer of *Sox3* is conserved poorly in the mouse genome, and this may account for the absence of *Sox3* expression during mouse lens development \[[@B6-biology-01-00714]\]. However, the *Sox3* D3 sequence, which showed purely otic placode-specific enhancer activity ([Figure 3](#biology-01-00714-f003){ref-type="fig"}), did not contain CSBs ([Figure 2](#biology-01-00714-f002){ref-type="fig"}), suggesting that this enhancer was unique to avian genomes.

Conservation of genomic sequences downstream of *Sox3*, as indicated by the occurrence of CSBs common to chicken, *Xenopus* and mammals, ends beyond CSB47, which is located at approximately 90 kb in the chicken genome, whereas the conservation among mammalian sequences is extended a further 3'. Both upstream and downstream genomic regions of the *Sox3* gene appeared to be expanded in the mammalian genomes compared to the chicken and *Xenopus* genomes. An interesting issue is whether this genomic expansion is correlated with the location of *Sox3* on the X-chromosome in mammalian species. The arrangements of landmark genes in syntenic chromosomal regions indicated extensive rearrangements of the genomic domains around the *Sox3* gene in various species ([Figure S1](#biology-01-00714-f007){ref-type="fig"}), suggesting that the genomic region investigated in this study included the major components of the *Sox3* regulatory sequences. Alternatively, the *Sox3* gene may be regulated by distant-acting regulatory sequences that withstand extensive genomic rearrangements.

4. Materials and methods
========================

4.1. Genome Sequences of the Sox3 Locus
---------------------------------------

To analyze the enhancers and conserved sequence blocks (CSBs) in the 231-kb region spanning the *Sox3* locus in the chicken genome, we used sequence data from Gallus gallus-4.0 assembly (GCA_000002315.2) chromosome 4 genomic scaffold sequence (NW_003763735 GPS_000848988) as a reference. The central region sequence, from -23456 to 29859, covered by our bacteriophage library \[[@B27-biology-01-00714]\] was determined by us (DDBJ Accession number AB753847). The translational start site of *Sox3* was taken as +1 to indicate the genomic location relative to *Sox3*. This position corresponded to *Gallus gallus* chromosome 4 NW_003763735 sequence position 10474038, *Homo sapiens* chromosome X GRCh37 partial sequence position 139587000 (*Sox3* is in reverse orientation), *Mus musculus* chromosome X GRCm38 partial sequence position 60893205 (*Sox3* is in reverse orientation), *Xenopus tropicalis* genome scaffold GL172698.1 position 1000090. The CSBs were screened using VISTA Browser (<http://genome.lbl.gov/vista/>) using a threshold of \>60% identity over a 100-bp length.

4.2. Enhancer Screening of the 233-kb Genomic Region and Characterization
-------------------------------------------------------------------------

The bacteriophage clones that carry the *Sox3*-proximal region sequences, approximately 50 kb, were used to produce the *Sox3*-proximal sequence segments C1-C13, and the two BAC clones CH261-112C13 and CH261-98D21 (ENSEMBL) were used to produce a series of \~5 kb DNA sequences with 1-kb terminal overlaps, U1 to U28 (upstream) and D1 to D17 (downstream), by PCR. These isolated sequences were individually inserted into a ptkEGFP vector \[[@B27-biology-01-00714]\], and electroporated at 2 μg/μL into the dorsal side of st. 4 chicken embryos. The pCMV-mRFP1 vector was also included in order to monitor the region of successful electroporation. The activation of EGFP expression at various developmental stages in New's culture was scored as enhancer activity.

4.3. Effector-Dependent Regulation of the NP1 Enhancer
------------------------------------------------------

pNP1\[218 bp\]-tkEGFP at 2 μg/μL, pCMV/SV2-mRFP1 at 0.6 μg/μL and pCAGGS-based expression vectors \[[@B40-biology-01-00714]\] at 2 μg/μL for the expression of Dkk1, stabilized β-catenin \[[@B29-biology-01-00714]\] or rFGFR1(ECD)-rFc(IgG2a) (gift of Claudio Stern) were electroporated in st. 4 embryos in New's culture. The impact of the expression of these effectors was assessed 8 hours after electroporation.
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biology-01-00714-t001_Table 1

###### 

Positioning of the conserved sequence blocks (CSBs) in the human, mouse, chicken and Xenopus genomes.

                  Chicken *Sox3* locus   Human *Sox3* locus   Mouse *Sox3* locus   Xenopus *Sox3* locus                                                                           
  --------------- ---------------------- -------------------- -------------------- ---------------------- ------- -------------------- ------ ------- -------------------- ------ -------
  1               -130257 \~ -130129     129                  -970154 \~ -970026   129                    84^c^   -589181 \~ -589053   129    82      Absent                      
  2               -110940 \~ -110700     241                  -444400 \~ -444161   240                    73      -522083 \~ -521837   247    74      Absent                      
  3               -108306 \~ -107937     370                  -428513 \~ -428153   361                    71      -500213 \~ -499841   373    69      -129767 \~ -129393   375    62
  4               -103688 \~ -103557     132                  Absent                                              -474215 \~ -474091   125    60      -121856 \~ -121723   134    64
  5               -97501 \~ -97400       102                  Absent                                              -388001 \~ -387900   102    62      Absent                      
  6               -82740 \~ -82535       206                  -274707 \~ -274502   206                    66      -286133 \~ -285930   204    53^d^   Absent                      
  7               -81558 \~ -81458       101                  Absent                                              -297179 \~ -297065   115    60      Absent                      
  8               -67333 \~ -67221       113                  -252300 \~ -252193   108                    57^d^   -261781 \~ -261669   113    63      Absent                      
  9               -60650 \~ -60531       120                  -246870 \~ -246750   121                    64      -253372 \~ -253247   126    64      Absent                      
  10              -59303 \~ -59126       178                  -243592 \~ -243410   183                    63      Absent                              Absent                      
  11              -56180 \~ -56079       102                  Absent                                              -230997 \~ -230897   101    61      Absent                      
  12              -45556 \~ -44996       561                  -156675 \~ -156165   511                    75      -149792 \~ -149283   510    75      -42634 \~ -42145     490    62
  13              -29736 \~ -29259       478                  -137259 \~ -136775   485                    79      -133617 \~ -133151   467    80      -31421 \~ -30964     458    60
  14              -26388 \~ -25483       906                  -88401 \~ -87521     881                    78      -101763 \~ -100874   890    79      -27373 \~ -26479     895    67
  15              -21081 \~ -20662       420                  -34050 \~ -33637     414                    77      -37248 \~ -36842     407    77      -19657 \~ -19236     422    65
  16              -17784 \~ -17128       657                  -28051 \~ -27389     663                    82      -25441 \~ -24780     662    81      -18039 \~ -17396     644    61
  17              -14950 \~ -14611       340                  -23177 \~ -22843     335                    76      -22166 \~ -21840     327    69      -15729 \~ -15389     341    60
  18              -13560 \~ -13273       288                  -22619 \~ -22337     283                    65      -21624 \~ -21340     285    63      Absent                      
  19              -11574 \~ -11339       236                  -21444 \~ -21219     226                    63      -20545 \~ -20316     230    51^d^   -13988 \~ -13757     232    71
  20              -5363 \~ -4690         674                  -7397 \~ -6739       659                    77      -6672 \~ -6014       659    76      -7241 \~ -6571       671    60
  21              -4176 \~ -4004         173                  Absent                                              Absent                              -5417 \~ -5246       172    64
  22              -944 \~ -792           153                  -1258 \~ -1099       160                    65      -1253 \~ -1097       157    65      Absent                      
  23              -88 \~ 997             1086                 -87 \~ 1166          1254                   67      -87 \~ 1177          1265   67      -88 \~ 969           1058   71
  *Sox3* CDS^b^                                               -225 \~ 1116         1342                           -225 \~ 1128         1354                                       
  *Sox3* CDS^a^   1 \~ 951               951                  1 \~ 1116            1116                   66      1 \~ 1128            1128   68      1 \~ 924             924    76
  24              1982 \~ 2098           117                  2253 \~ 2378         126                    68      2247 \~ 2369         123    64      Absent                      
  25              20709 \~ 20882         174                  48743 \~ 48914       172                    67      45466 \~ 45638       173    67      Absent                      
  26              24291 \~ 24916         626                  54918 \~ 55541       624                    70      51461 \~ 52097       637    70      22831 \~ 23470       640    70
  27              29103 \~ 29471         369                  64927 \~ 65286       360                    63      61426 \~ 61785       360    61      24237 \~ 24595       359    76
  28              33725 \~ 33839         115                  Absent                                              Absent                              28864 \~ 28991       128    63
  29              35797 \~ 35915         119                  114633 \~ 114750     118                    61      93771 \~ 93888       118    61      31915 \~ 32036       122    61
  30              37839 \~ 37943         105                  Absent                                              Absent                              50701 \~ 50801       101    69
  31              43240 \~ 43490         251                  146259 \~ 146505     247                    60      115905 \~ 116157     253    60      Absent                      
  32              47105 \~ 47964         860                  205211 \~ 206065     855                    79      148542 \~ 149384     843    76      59011 \~ 59847       837    63
  33              48341 \~ 48713         373                  206395 \~ 206764     370                    72      149726 \~ 150095     370    72      61798 \~ 62162       365    60
  34              52194 \~ 52648         455                  253981 \~ 254434     454                    86      173018 \~ 173471     454    86      66646 \~ 67075       430    71
  35              60282 \~ 60540         259                  314971 \~ 315223     253                    67      212815 \~ 213069     255    69      82061 \~ 82322       262    56^d^
  36              69025 \~ 69166         142                  325798 \~ 325935     138                    61      235698 \~ 235833     136    62      Absent                      
  37              69205 \~ 69439         235                  325967 \~ 326202     236                    61      235872 \~ 236110     239    60      Absent                      
  38              71699 \~ 72240         542                  346769 \~ 347310     542                    82      262559 \~ 263101     543    73      93894 \~ 94430       537    65
  39              75210 \~ 75377         168                  376498 \~ 376664     167                    84^c^   Absent                              95795 \~ 95968       174    71
  40              77117 \~ 77242         126                  393019 \~ 393146     128                    69      322436 \~ 322565     130    60      Absent                      
  41              77293 \~ 77414         122                  393172 \~ 393292     121                    62      322599 \~ 322709     111    50^d^   Absent                      

^a^ The open reading frame (ORF) start site of *Sox3* is taken as 1.

^b^ Another translational start sites are annotated and conserved only in some mammalian genomes.

^c^ The case where the sequence was inverted relative to chicken sequence.

^d^ The cases where the sequence showed sequence identity vs chicken below 60%.

biology-01-00714-t002_Table 2

###### 

Positioning of the DNA sequences relative to the *Sox3* ORF start site, which were tested for enhancer activity.

  Sequence number   Positions relative to the *Sox3* start site (bp)   Sequence length (bp)   Enhancer activity in the CNS (HH stages^a^)                       Non-CNS enhancer activity (HH stages^a^)   Analyzed specimens
  ----------------- -------------------------------------------------- ---------------------- ----------------------------------------------------------------- ------------------------------------------ --------------------
  U28               -134079 \~ -129036                                 5044                   \-                                                                \-                                         3
  U27               -130087 \~ -125081                                 5007                   \-                                                                \-                                         7
  U26               -126128 \~ -121082                                 5047                   \-                                                                \-                                         8
  U25               -122088 \~ -117083                                 5006                   \-                                                                \-                                         3
  U24               -118083 \~ -113121                                 4963                   \-                                                                \-                                         4
  U23               -114084 \~ -109748                                 4337                   \-                                                                \-                                         4
  U22               -110784 \~ -106313                                 4472                   \-                                                                \-                                         5
  U21               -107300 \~ -102342                                 4959                   \-                                                                \-                                         9
  U20               -103342 \~ -98324                                  5019                   \-                                                                \-                                         5
  U19               -99343 \~ -94344                                   5000                   \-                                                                \-                                         6
  U18               -95344 \~ -90289                                   5056                   \-                                                                \-                                         4
  U17               -91345 \~ -86346                                   5000                   \-                                                                \-                                         4
  U16               -87346 \~ -82309                                   5038                   \-                                                                \-                                         6
  U15               -83347 \~ -78332                                   5016                   \-                                                                \-                                         8
  U14               -79348 \~ -74349                                   5000                   \-                                                                \-                                         2
  U13               -75351 \~ -70345                                   5007                   \-                                                                \-                                         3
  U12               -71350 \~ -66311                                   5040                   \-                                                                \-                                         3
  U11               -67351 \~ -62352                                   5000                   \-                                                                \-                                         4
  U10               -63400 \~ -58258                                   5143                   \-                                                                \-                                         5
  U9                -59365 \~ -54312                                   5054                   \-                                                                \-                                         3
  U8                -55353 \~ -50146                                   5208                   \-                                                                \-                                         6
  U7                -51354 \~ -46353                                   5002                   \-                                                                \-                                         9
  U6                -47369 \~ -42356                                   5014                   \-                                                                \-                                         8
  U5                -43364 \~ -38357                                   5008                   \-                                                                \-                                         3
  U4                -39363 \~ -34454                                   4910                   \-                                                                \-                                         3
  U3                -35550 \~ -30442                                   5109                   \-                                                                Epibranchial placode (st. 9)               13
  U2                -31484 \~ -26456                                   5029                   \-                                                                \-                                         3
  U1                -27456 \~ -22435                                   5022                   \-                                                                \-                                         5
  C1                -23456 \~ -16912                                   6545                   \-                                                                \-                                         4
  C2                -22029 \~ -14489                                   7541                   \-                                                                \-                                         7
  C3                -16915 \~ -12683                                   4233                   \-                                                                \-                                         4
  C4                -16353 \~ -10686                                   5668                   \-                                                                Lens placode(st. 11)                       4
  C5                -13647 \~ -9325                                    4323                   \-                                                                Lens placode(st. 11)                       6
  C6                -10822 \~ -6096                                    4727                   \-                                                                \-                                         2
  C7                -7397 \~ 2548                                      9945                   \-                                                                \-                                         5
  C8                -2027 \~ 6462                                      8489                   \-                                                                \-                                         5
  C9                4748 \~ 15637                                      10890                  \-                                                                \-                                         5
  C10               6459 \~ 11599                                      5141                   \-                                                                \-                                         4
  C11               13024 \~ 21441                                     8418                   \-                                                                \-                                         3
  C12               16899 \~ 29642                                     12744                  Diencephalon, spinal cord (st.11)                                 \-                                         8
  C13               21752 \~ 28244                                     6493                   Diencephalon, spinal cord (st.11)                                 \-                                         8
  D1                28860 \~ 33859                                     5000                   Posterior neural plate, rhombencephalon, spinal cord (st. 5)      Otic placode (st. 11)                      15
  D2                32859 \~ 37858                                     5000                   \-                                                                \-                                         3
  D3                36858 \~ 41867                                     5010                   \-                                                                Otic placode (st. 11)                      11
  D4                40830 \~ 45856                                     5027                   Telencephalon (st. 9)                                             \-                                         11
  D5                44847 \~ 49855                                     5009                   Tel/di/mesencephalon (st. 9)                                      Lens placode (st. 11)                      12
  D6                48830 \~ 53858                                     5029                   Mes/rhombencephalon, spinal cord (st. 15)                         \-                                         8
  D7                52798 \~ 57856                                     5059                   \-                                                                \-                                         3
  D8                56853 \~ 61861                                     5009                   \-                                                                Epibranchial placode (st. 9)               7
  D9                60834 \~ 65872                                     5039                   \-                                                                Lens (st. 17)^b^                           3
  D10               64835 \~ 69850                                     5016                   Ventral diencephalon (st. 13)^b^                                  Otic vesicle, nasal pit (st. 13)^b^        3
  D11               68843 \~ 73849                                     5007                   Spinal cord (st. 9)                                               \-                                         10
  D12               72849 \~ 77848                                     5000                   Diencephalon (st. 11)                                             \-                                         11
  D13               76848 \~ 81847                                     5000                   Posterior neural plate, di/rhombencephalon, spinal cord (st. 8)   \-                                         12
  D14               80847 \~ 85895                                     5049                   \-                                                                \-                                         3
  D15               84850 \~ 88760                                     3911                   CNS (st. 8)                                                       \-                                         3
  D16               88029 \~ 93228                                     5200                   \-                                                                \-                                         3
  D17               92231 \~ 97230                                     5000                   \-                                                                \-                                         5
  CSB19             -12377 \~ -10964                                   1414                   \-                                                                Lens placode (st. 11)                      3
  CSB26             24264 \~ 25312                                     1049                   Diencephalon, spinal cord (st. 11)                                \-                                         5
  CSB27             28179 \~ 29859                                     1681                   Posterior neural plate, rhombencephalon, spinal cord (st. 5)      Otic placode (st. 11)                      37

^a^ The earliest developmental stages recorded for the EGFP expression are indicated.

^b^ These showed the low enhancer activities, and data were not shown in this text.
